Tumor Heterogeneity of the Tumor Microenvironment in Malignant Pleural Mesothelioma (MPM)

Overview

Información sobre este estudio

The purpose of this study is to:

  1. Evaluate MPM tumor heterogeneity by determining the agreement of histology, molecular abnormalities, neo-antigen expression and immunological biomarkers between three tumor samples from MPM patients.

  2. Compare the information from tumor samples to pleural fluid, peripheral blood and density based radiomics analysis.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria

  1. Subject provides informed consent
    1. Subject is >18 years of age
    2. Subject is deemed competent for making medical decisions
  2. Subjects with MPM and pleural effusion who are treatment naïve
  3. Subject is scheduled to undergo pleuroscopy, mediastinoscopy, thoracotomy, or laparascopy as part of their standard care for MPM.
  4. A negative pregnancy test is required in women of child-bearing potential, as standard of care.
  5. Subject is mentally capable of understanding study procedures.

Exclusion Criteria

  1. Study subject has any disease or condition that interferes with safe completion of the study including:
    1. Platelet count < 50K, coagulopathy defined as an International Normalized Ratio (INR) > 1.5
    2. Anticoagulants such as clopidogrel, heparin, low-molecular weight heparin, warfarin or other novel anticoagulants have not been held for the standard time period published.
    3. Hemodynamic instability with systolic blood pressure <90 mmHg or heart rate > 120 beats/min, unless deemed to be stable with these values by the surgical or interventional pulmonary attending physicians.
    4. Hypoxemia with pulse oximetry values <88% or partial pressure of oxygen in arterial blood (PaO2) < 60 on baseline oxygen requirements, unless deemed to be stable with these values by the surgical or interventional pulmonary attending physicians
  2. Concurrent participation in another study involving investigational drugs or investigational medical devices
  3. Absence of or limited access to the pleural space during pleuroscopy.
  4. Inability to read and understand the necessary study documents.

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Tobias Peikert, M.D.

Cerrado para la inscripción

Contact information:

Amanda Calvin M.D.

Mccambridge.Amanda@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20389240

Mayo Clinic Footer